Drug‐receptor dissociation time, new tool for drug research: Receptor binding affinity and drug‐receptor dissociation profiles of serotonin‐S2, Dopamine‐D2, histamine‐H1 antagonists, and opiates
- 1 May 1986
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 8 (1-4), 119-131
- https://doi.org/10.1002/ddr.430080115
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The serotonin‐S2 Receptor: A receptor‐transducer coupling model to explain insurmountable antagonist effectsDrug Development Research, 1986
- A Double‐Blind Evaluation of Topical Levocabastine, a New Specific H1 Antagonist in Patients with Allergic ConjunctivitisAllergy, 1985
- Different effects of serotonin antagonists on 3H-mianserin and 3H-ketanserin recognition sitesLife Sciences, 1985
- Pharmacology of Potent and Selective S2-Serotonergic AntagonistsJournal of Cardiovascular Pharmacology, 1985
- The Dissociation Rate of Unlabelled Dopamine Antagonists and Agonists from the Dopamine-D2Receptor, Application of an Original Filter MethodJournal of Receptor Research, 1984
- [3H]sufentanil, a superior ligand for μ-opiate receptors: Binding properties and regional distribution in rat brain and spinal cordEuropean Journal of Pharmacology, 1983
- The in vivo pharmacological profile of histamine (H1) antagonists in the ratDrug Development Research, 1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Oxatomide: The Prototype of a Chemical Series of Compounds Inhibiting Both the Release and the Effects of Allergic MediatorsPublished by American Chemical Society (ACS) ,1980
- Differentiation of opiate and neuroleptic receptor binding in rat brainEuropean Journal of Pharmacology, 1977